Why
Isn't the H1N1 Pandemic Flu Being Investigated as a Designed Bioweapon?
Strange as
it may seem, in an era of heightened concern about biological
terrorism, there appears to be little or no talk about the triple-reassortant
H1N1 pandemic flu virus as a laboratory-designed bioweapon.
Certainly,
this is not out of the question technologically. It is
now entirely possible for scientists to artificially re-create
an infectious agent from scratch. Researchers have demonstrated
that a polio virus can be reduced to a chemical, C332, 652H492,
388N98, 245O131, 196-P7501S2340,
and assembled by following its written genetic code. (Viruses
are not live organisms, they are sequences of genes that must
rely upon entry into a host cell nucleus to utilize the cell's
genetic mechanisms for reproduction.) When a synthetically-created
polio virus was introduced into the spinal cords of mice it created
the same paralysis seen in polio.1
The synthesis
of flu viruses became more than a possibility in 1999 when researchers
demonstrated it was possible to overcome the previously insurmountable
problem of arranging eight segments of RNA. This was accomplished
by generation of RNA using an enzyme, RNA polymerase, essentially
creating a cloned flu virus.2
Fear spreads
faster than the flu
Certainly
imagined rather than factually-based fear is at the core of concern
over this H1N1 pandemic flu outbreak. Tuberculosis, another infectious
disease, globally kills nearly 2 million every year, compared
to 250,000-500,000 from the flu, but a $9 billion effort to eradicate
it is not mounted against TB as has occurred with the 2009 "swine
flu."
The lateflu
season introduction of the pandemic, starting in Mexico in March
of 2009, creates a similar frightening scenario to the 1918 Spanish
flu outbreak that killed millions worldwide. If an engineered
virus, its late-season introduction could be evidence of an intentional
effort to panic human populations.
If designed,
it was intended to spread, not kill. It lacks the PB1-F2 marker
for pathogenicity (tissue damage) seen in the dreaded but poorly
transmitted H5N1 bird flu virus that drew concern in 2003.3
Yet, in vulnerable individuals, those with pre-existing disease
or smokers or pregnant females, there is a greater (though still
small) risk of death.
Wishy-washy
origins
Researchers
attempt to explain that this unique flu virus "was derived
from several viruses circulating in swine, and that initial transmission
to humans occurred several months before recognition of the outbreak."
Without evidence in hand, the world community of virologists concluded
that this virus "emerged from a triple reassortant virus
circulating in North American swine." Yet no mass culling
of herds of swine was called for.6
The swine
origin of this flu is nonsense since no swine herds exhibited
this virus till detection months following the initial flu outbreak
in Mexico, suggesting it was transmitted from humans to pigs,
not the other way around. Using pigs as a cover for the true origin
of the disease also suggests a broad cover-up within the community
of microbiologists and public health authorities.
For factual
documentation, the first detection by the US Department of Agriculture
of H1N1 pandemic influenza in pigs in the US occurred between
August 26 and September 1 at the Minnesota State Fair, almost
6 months after the first case in Mexico.4
However, this
fact was not revealed till months later, claimed to be an effort
to protect US pig farmers when their business had already been
destroyed by association of this flu virus with flu strains commonly
found in swine herds.5
Researchers
go on to say, in a confusing and inexplicable fashion, that "a
phylogenetic estimate of the gaps in genetic surveillance indicates
a long period of unsampled ancestry before the swine-flu outbreak,
suggesting that the reassortment of swine lineages may have occurred
years before emergence in humans, and that the multiple genetic
ancestry of this swine flu is not indicative of an artificial
origin."6
Here is intentional
wording to dismiss any thought of an engineered virus. Yet the
authors of this report are suggesting the many flu-monitoring
stations across the globe completely missed detection of this
virus as it mutated and re-assorted into its current form. Yet
there has been no call to check for flaws in classifying viral
strains which would have obviously occurred.
These researchers
go on to say, that without samples of its ancestors, the immediate
origin of this flu strain is difficult to determine. The closest
relatives to this flu strain existed between 9.2 and 17.2 years
ago, "depending upon the genetic segment" analyzed.
Investigators claim it must have been circulating in pigs "for
several years" before emergence in humans.6
Its Asian-origin
flu strain segments lead researchers to blame the movement of
pigs between Eurasia and North America for its unique viral re-assortment.
Yet shipment of swine herds is one way, from North America to
Asia, and there are quarantine periods so that new arrivals don't
infect an existing herd. Influenza lasts only a few days and quarantine
methods would eliminate any transfer to another herd. Unlike humans,
pigs produce their own vitamin C and swine herd flu outbreaks
are typically mild and not mortal.
Warning
of influenza as a bioweapon
In 2003
researchers at the Center for Biosecurity and Public Health,
University of Texas-Houston Health Center, Houston, Texas, warned
that influenza could be made into a bioweapon to produce disease
and death of major proportion. Unlike other biological threats
like anthrax, influenza only requires 3 to 6 airborne viral particles,
27,000 times fewer viral particles than obtained by direct contact
(hands) to produce infection. In 14 days, its incubation
period, it can start replicating and producing symptoms of diarrhea,
vomiting and coughing serious enough for hospitalization and use
of a respirator. Its victims often succumb to a sudden mortal
heart attack, which does not directly end up on statistical health
summaries as flu-related death.7
Once a flu
pandemic has begun it is difficult to halt because immunization
after exposure to the flu is not protective, and anti-flu drugs
(Tamiflu, Relenza) must be administered before symptoms develop
or within the first 48 hours after their appearance. Early on,
flu symptoms may appear similar to other biological threats like
anthrax, so it is difficult to ascertain that a human population
is under an intentional biological attack.8
Flu viruses
evolve to protect humanity?
Jeffery K.
Taubenberger, M.D., Ph.D. Senior Investigator in National Institute
of Allergy & Infectious Diseases, and Anthony S. Fauci, M.D.,
Director of that Institute, say theH1N1 pandemic flu is afourth-generation
descendantof the 1918 virus.
This virus
caused an explosiveand historic pandemic, during which humans
also transmittedthe virus to pigs, they concede. Taubenberger
and Fauci take evolutionary theory to the height of its absurdity
by stating:
"...successive
pandemics and pandemic-likeevents generally appear to be decreasing
in severity over time.This diminution...may reflect viral evolutionary
'choices' that favor optimal transmissibility with minimal pathogenicity
- a virus that kills its hosts or sends them to bed isnot optimally
transmissible."
Huh? We've
heard of "survival of the fittest," and "natural
selection" (where heritable traits make it more likely
an organism will survive and successfully reproduce itself), but
here we have a new and novel definition of evolution - the flu
virus genome is selecting against its own survival in preference
to survival of humans!8
How a tailored
flu virus would be produced
In 2003 Robert
M. Krug, writing in the journal Antiviral Research, wrote a landmark
report entitled "The potential use of influenza virus
as an agent for bioterrorism." Krug said:
"If
such a lethal human influenza A virus does not emerge in nature,
it is likely that it can be generated in the laboratory, utilizing
the recently developed reverse genetic system, whereby influenza
viruses can be generated by transfection (a process of introducing
nucleic acids into cells) of multiple DNAs."15
This can be
accomplished by transiently opening pores or holes in the cell
membrane to allow entrance of viral particles. In fact, the deadly
H5N1 bird flu virus (kills 6 in 10 infected humans) has already
been generated in at least one laboratory at the University of
Wisconsin using this reverse genetic system.9
This topic
was covered in my LRC article entitled "The Deadliest
Flu Virus In The World."10
Krug writes:
"There
is every reason to believe that the same recombinant DNA techniques
can be used to render this H5N1 virus transmissible from humans
to humans. Furthermore, it should be possible to introduce mutations
into such a recombinant virus so that it is resistant to currently
available influenza virus antivirals (M2 inhibitors: amantadine
and rimantadine; and NA inhibitors: zanamivir and oseltamivir-Tamiflu
and Relenza), and so that it is unlike... recently circulating
human viruses. In fact, several viruses (at one time)...could
be generated. The human population would lack immunological
protection against such viruses, existing antiviral drugs would
not afford any protection, and these viruses could be spread
simply by release of an aerosol spray in several crowded areas."15
In this instance,
if the current H1N1 pandemic flu virus was engineered, it was
designed to be vulnerable to Tamiflu and Relenza, but not amantadine
and rimantadine. With the current delay in delivery of the vaccine,
one wonders if this whole pandemic hasn't been engineered to deplete
aging stocks of Tamiflu that nations have been piling up in anticipation
of "the big one" - the supposed long-overdue
"great flu pandemic."
The question
is, could there be some villainous bioterrorist in some foreign
country who has the capability of covertly starting a flu virus
in a remote village in Mexico, and only infect one child there,
and then see it spread around the world? If so, this flu pandemic
actually petered out by July of 2009, as CBS News uncovered, but
re-emerged in the following months as the dominant strain of flu
virus in circulation.11
Pandemic
flu strains predominates
Was this pandemic
strain of the flu re-introduced or re-engineered at that time,
to make it more prevalent?
The current
strain of the flu in circulation as of the first week in November
2009 is 99% H1N1 pandemic strain. The seasonal flu strains have
vanished. There is no need to undergo vaccination for seasonal
flu. Health authorities knew some time ago that the H1N1 pandemic
flu strain overwhelms seasonal flu strains. The exact date of
that discovery is unclear because we only have the date of publication
of that discovery. The first evidence for this was produced some
time earlier.12
Whether a
biological terrorist re-introduced the H1N1 strain into North
American human populations after it was fizzling out in July is
certainly speculation, but is a question that needs asking.
Laboratory
origin: no amateur bioterrorists
Krug goes
on to say:
"It
can be argued that most terrorists would not have the knowledge,
facilities and ingenuity to carry out these recombinant DNA
experiments. This is probably the case at the present time,
but the situation can be expected to change in the future, perhaps
after as little as 5-10 years."15
Currently
there is no revealed intelligence that there is a nefarious bioterrorist
at large developing pandemic flu viruses. If the current pandemic
flu strain in circulation was designed in a laboratory, it would
likely be a university or military lab, just as the origin of
anthrax was traced back to the Army lab at Fort Detrick in Maryland.13
We should
also not forget that the news media repeatedly attempted to distract
the public as to the real origins of the anthrax, falsely suggesting
the bentonite additive found in the anthrax samples, spread in
the ventilation ducts at offices of US Congressmen in Washington
DC, originated in Iraq, the only country known to use that additive.
A false connection was being made between the anthrax and Iraqi
leader Saddam Hussein by ABC chief investigative correspondent
Brian Ross on October 26, 2001, shortly following the attacks
on the World Trade Center in New York.14
So the public should be wary of the news media that may be complicit
with other sources to create politically-correct conclusions as
to the origin of the H1N1 swine flu.
Vaccination
strategy is inherently flawed
Krug goes
on to say:
"Vaccination
will probably be of limited value against an influenza virus
bioterrorist attack. Currently it takes about 6 months to prepare
a vaccine against a new influenza virus strain. Perhaps reverse
genetic approaches can shorten this time somewhat, but there
will still be a few months between an influenza virus outbreak
and the availability of a protective vaccine. In addition, the
vaccine approach can be readily thwarted by bioterrorists who
could spread several influenza viruses with different HA antigenic
sites."15
So the current
effort to control influenza, largely being centered on vaccination,
is flawed and should be curtailed. Of course, that is not what
is being played out in the currently unfolding vaccine drama
Only antivirals
are left in defense
Krug then
says: "In contrast, antiviral drugs that are directed
at functions shared by all influenza A virus strains constitute
the best line of defense against a bioterrorist attack. Currently
the NA (neuraminidase) inhibitors (zanamivir and oseltamivir-Tamiflu
and Relenza) are the only such antivirals available."15
Stockpiles
of anti-viral drugs, which now proliferate across the globe, could
become useless due to limited shelf life. So far, manufacturers
have been testing and extending the shelf life of their anti-viral
products. The World Health Organization holds 2 million treatment
courses of Tamiflu and another 3 million courses are held in stock
by Roche as part of their rapid response stockpile.16
Anti-virals
are somewhat effective in prophylaxis of the flu, but over-use
of these anti-viral drugs induces viral resistance.17
It is interesting
to note that 99.6% of the 2008 seasonal flu strains were resistant
to Tamiflu.18 To move Tamiflu off
of shelves, the seasonal flu had to vanish, which is exactly what
has occurred. This suggests aerosol flu viruses are being seeded
into the population to create designed flu pandemics.
As mentioned
earlier in this report, the H1N1 pandemic flu now in circulation
has virtually overtaken all other flu strains, as if by design,
in an apparent attempt to deplete the millions of doses of Tamiflu
whose shelf life expires in 20092010. The US has a stockpile
of over 50 million doses to clear off its shelves that outdates
soon.19
Vaccine
makers, government, presage the pandemic
For unexplained
reasons, in 2008 the manufacturer of Tamiflu in Japan projected
a 531% increase in sales in 2009, as if presaging the flu pandemic
now underway.20
Has this whole
flu escapade, its late-season onset, the otherwise inexplicable
delays in delivery of the vaccine, been staged to dump millions
of nearly-outdated Tamiflu pills on the world masses who have
been whipped up into flu hysteria?
On June 27,
2008, nearly 8 months prior to the first reports of the H1N1 pandemic
flu emanating out of Mexico, the maker of Tamiflu began urging
companies to buy stockpiles of their product, a sales effort that
was endorsed by the Department of Health & Human Services.
This suggests massive collusion between the makers of anti-viral
drugs and public health authorities in staging this pandemic.
On June 27,
2008, a deputy secretary for the Department of Health & Human
Services is quoted as saying: "I think the (Tamiflu) program
is unprecedented in that we are facing an unprecedented threat."21
Exactly which unprecedented flu threat was this government employee
talking about at the time?
References:
- Cello
J, Paul AV, Wimmer E, Chemical
Synthesis of Poliovirus cDNA: Generation of Infectious Virus
in the Absence of Natural Template Science 297, 1016
(2002).
- Neumann
G, Kawaoka Y, Synthesis
of influenza virus: new impetus from an old enzyme, RNA polymerase
I. Virus Research. 2002 Jan 30; 82(12):1538.
- Wang TT,
Palese P, Unraveling
the Mystery of Swine Influenza Virus Cell 137, June
12, 2009.
- Petrosillo
N, Di Bella S, Drapeau CM, Grilli E, The
novel influenza A (H1N1) virus pandemic: An update. Annals
Thoracic Medicine. 2009 Oct;4(4):16372.
- United
States USDA take 3 months to disclose swine flu.
Meat Trade News Daily Nov. 4, 2009.
- Smith
GJD, Vijakrishna D, Bahl J, et al, Origins and evolutionary
genomics of the 2009 swine-origin H1N1 influenza A epidemic.
Nature Volume 459, 25 June 2009. https://www.ncbi.nlm.nih.gov/pubmed/11885943
- Madjid
M, Lillibridge S, Mirhaji P, Casscells W, Influenza
as a bioweapon. Journal Royal Society Medicine 2003 96 (7);
34546.
- Morens
DM, Taubenberger JK, Fauci AS, The Persistent Legacy of the
1918 Influenza Virus. New England Journal Medicine 361(3): 22529,
July 16, 2009.
- Hatta
M, Gao P, Halfmann P, Kawaoka Y, Molecular
basis for high virulence of Hong Kong H5N1 influenza A viruses.
Science 2001 Sep 7; 293(5536):18402.
- The
Deadliest Flu Virus in the World: Made in USA.
- Atkinson
S, Swine
flu cases overestimated? CBS News Oct. 21, 2009.
- Perez,
D., Sorrell, E., Angel, M., Ye, J., Hickman, D., Pena, L., Ramirez-Nieto,
G., Kimble, B., & Araya, Y. August 25, 2009. Fitness
of Pandemic H1N1 and Seasonal influenza A viruses during Co-infection
PLoS Currents RRN1011.2.
- Anthrax
attack bug "identical" to army strain." New Scientist.
May 9, 2002.
- Troubling
Anthrax Additive Found, Brian Ross, Christopher Isham, Chris
Vlasto and Gary Matsumoto, ABC.com, October 26, 2001
- Krug RM,
The potential use of influenza virus as an agent for bioterrorism.
Antiviral Research 57 (2003) 147-150.
- Roche
deploys rapid response stockpile of Tamiflu Reuters Sat
May 2, 2009.
- Eichner
M, Schwehm M, Duerr HP, et al, Antiviral prophylaxis during
pandemic influenza may increase drug resistance. BMC Infectious
Diseases 2009; 9: 233439.
- "20082009
Influenza Season Week ending September 5, 2009 "CDC,
Sep. 18, 2009.
- Stockpiled
Antivirals at or Nearing Expiration. US Food & Drug
Administration.
- Chugai
Pharmaceutical, Annual Report 2008.
- Mary Brophy
Marcus, U.S.
firms can stockpile Tamiflu. USA TODAY June 27, 2008.
Reference Sources :
lewrockwell.com
November
10, 2009
...............................................................................................................
|